Actively Recruiting
Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome
Led by Rabin Medical Center · Updated on 2024-12-19
120
Participants Needed
1
Research Sites
91 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
H syndrome is a rare genetic disorder predisposing to histiocytosis. Our knowledge of the clinical spectrum of these patients is based on case reports and small patient series. Patients with H syndrome have been treated with a range of immunomodulatory and chemotherapeutic agents, with limited success. We aim to comprehensively assess the clinical manifestations and patterns of treatment response in a multinational cohort of patients with H syndrome.
CONDITIONS
Official Title
Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Any patient with a genetically confirmed diagnosis of H syndrome
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Schneider Children's Medical Center
Petah Tikva, Israel
Actively Recruiting
Research Team
S
Sarah Elitzur, MD
CONTACT
N
Naomi Litichever, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here